Details for New Drug Application (NDA): 211712
✉ Email this page to a colleague
The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pindolol profile page.
Summary for 211712
Tradename: | PINDOLOL |
Applicant: | Bayshore Pharms Llc |
Ingredient: | pindolol |
Patents: | 0 |
Pharmacology for NDA: 211712
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 211712
Suppliers and Packaging for NDA: 211712
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PINDOLOL | pindolol | TABLET;ORAL | 211712 | ANDA | Bryant Ranch Prepack | 63629-4828 | 63629-4828-1 | 180 TABLET in 1 BOTTLE, PLASTIC (63629-4828-1) |
PINDOLOL | pindolol | TABLET;ORAL | 211712 | ANDA | PD-Rx Pharmaceuticals, Inc. | 72789-099 | 72789-099-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-099-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Aug 1, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 1, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription